TAKEDA PHARMACEUTICAL : Form 6-K - MarketScreener
Document FORM 6-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
Source: marketscreener.com
Stay updated with breaking news from Partial Correction. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Document FORM 6-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
March 15, 2024 To whom it may concern: Abalance Corporation Representative Director and President Mitsuyuki Yasuaki ...
March 14, 2024 To whom it may concern: Abalance Corporation Representative Director and President Mitsuyuki Yasuaki ...
This document is an unofficial translation of Notice of Partial Correction to Notice of 27th Annual General Shareholders' Meeting and is provided for your convenience only, without...